Pancragen is a synthetic short peptide bioregulator belonging to the Khavinson peptide family, originally developed through research at the St Petersburg Institute of Bioregulation and Gerontology. As a tetrapeptide, Pancragen is specifically studied in the context of pancreatic tissue function, where it is believed to interact with DNA regulatory sequences to influence gene expression within pancreatic cells.
In preclinical research settings, Pancragen has been investigated for its potential role in normalising pancreatic peptide synthesis, supporting endocrine and exocrine pancreatic activity, and modulating metabolic processes associated with glucose regulation. These properties make it of particular interest in studies relating to metabolic health, ageing, and pancreatic tissue integrity.
Pancragen is supplied by Peptician as a lyophilised powder of greater than 98% purity, ensuring reliable and reproducible results in laboratory investigations. Its compact tetrapeptide structure offers good stability when stored correctly.
Storage: Store at -20°C, away from light and moisture. Stable for up to 24 months when stored correctly.
Molecular Formula
C₂₀H₃₁N₅O₉
Molecular Weight
484.5 g/mol
Purity
>98%
CAS Number
1116690-55-1
Form
Lyophilised Powder
Research Applications
Pancreatic function research, Metabolic regulation studies, Endocrine system investigation, Gerontology and ageing research, Glucose homeostasis studies, Peptide bioregulator research
For research purposes only. Not for human use.
Reviews
There are no reviews yet.